Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.

European review for medical and pharmacological sciences

Volumn 16, Issue 11, 2012, Pages 1519-1524

  Basturk, T ^a   Unsal, A ^b   Ulas, T ^b   Koc, Y ^b   Sakaci, T ^b   Ahbap, E ^b   Borlu, F ^b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873418704     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)